Azithromycin for treatment of hospitalised COVID-19 patients: a randomised, multicentre, open-label clinical trial (DAWn-AZITHRO).

Gyselinck I, Liesenborghs L, Belmans A, Engelen MM, Betrains A, Van Thillo Q, Nguyen PAH, Goeminne P, Soenen AC, De Maeyer N, Pilette C, Papleux E, Vanderhelst E, Derweduwen A, Alexander P, Bouckaert B, Martinot JB, Decoster L, Vandeurzen K, Schildermans R, Verhamme P, Janssens W, Vos R

Open source

DOI: 10.1183/23120541.00610-2021
Published: 2022 Jan
Container: ERJ open research
Publisher: Not recorded
Open access: yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

cautionDOI registered: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
cautionDOI resolves: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
supportingOpen access status: Normalized open-access status: open. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.1183/23120541.00610-2021,
  title = {Azithromycin for treatment of hospitalised COVID-19 patients: a randomised, multicentre, open-label clinical trial (DAWn-AZITHRO).},
  author = {Gyselinck I and Liesenborghs L and Belmans A and Engelen MM and Betrains A and Van Thillo Q and Nguyen PAH and Goeminne P and Soenen AC and De Maeyer N and Pilette C and Papleux E and Vanderhelst E and Derweduwen A and Alexander P and Bouckaert B and Martinot JB and Decoster L and Vandeurzen K and Schildermans R and Verhamme P and Janssens W and Vos R},
  year = {2022},
  journal = {ERJ open research},
  doi = {10.1183/23120541.00610-2021},
  url = {https://doi.org/10.1183/23120541.00610-2021}
}

RIS

TY  - JOUR
TI  - Azithromycin for treatment of hospitalised COVID-19 patients: a randomised, multicentre, open-label clinical trial (DAWn-AZITHRO).
AU  - Gyselinck I
AU  - Liesenborghs L
AU  - Belmans A
AU  - Engelen MM
AU  - Betrains A
AU  - Van Thillo Q
AU  - Nguyen PAH
AU  - Goeminne P
AU  - Soenen AC
AU  - De Maeyer N
AU  - Pilette C
AU  - Papleux E
AU  - Vanderhelst E
AU  - Derweduwen A
AU  - Alexander P
AU  - Bouckaert B
AU  - Martinot JB
AU  - Decoster L
AU  - Vandeurzen K
AU  - Schildermans R
AU  - Verhamme P
AU  - Janssens W
AU  - Vos R
PY  - 2022
JO  - ERJ open research
DO  - 10.1183/23120541.00610-2021
UR  - https://doi.org/10.1183/23120541.00610-2021
ER  -

APA

I, G., L, L., A, B., MM, E., A, B., Q, V. T., PAH, N., P, G., AC, S., N, D. M., C, P., E, P., E, V., A, D., P, A., B, B., JB, M., L, D., K, V., R, S., P, V., W, J., & R, V. (2022). Azithromycin for treatment of hospitalised COVID-19 patients: a randomised, multicentre, open-label clinical trial (DAWn-AZITHRO).. ERJ open research. https://doi.org/10.1183/23120541.00610-2021

Source records

pubmed · retrieved 2026-09-27T15:59:18.020Z